- Home
- VIVS vs SDOT Comparison
VIVS vs SDOT Comparison
Compare VIVS & SDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VIVS | SDOT |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 7.6M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | VIVS | SDOT |
|---|---|---|
| Price | $2.00 | $2.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 35.5K | ★ 119.7K |
| Earning Date | 11-06-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $140,000.00 | ★ $467,078,000.00 |
| Revenue This Year | $42.38 | $12.76 |
| Revenue Next Year | $15.42 | $5.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 35.92 | N/A |
| 52 Week Low | $1.41 | $1.20 |
| 52 Week High | $21.96 | $40.80 |
Technical Indicators
Market Signals| Indicator | VIVS | SDOT |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 31.58 |
| Support Level | $1.82 | $2.07 |
| Resistance Level | $2.10 | $3.54 |
| Average True Range (ATR) | 0.17 | 0.30 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 26.27 | 32.00 |
Price Performance
Historical ComparisonAbout VIVS VivoSim Labs Inc.
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.